Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Unknown 8Not yet recruiting 6Recruiting 4Terminated 2Suspended 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Nasopharyngeal Carcinoma 19Triple Negative Breast Neoplasms 11Breast Neoplasms 10Carcinoma, Non-Small-Cell Lung 7Head and Neck Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Neoplasms 5Colorectal Neoplasms 5Advanced Solid Tumor 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Esophageal Squamous Cell Carcinoma 4Carcinoma, Transitional Cell 4Carcinoma, Renal Cell 4Solid Tumor 3Small Cell Lung Carcinoma 3Recurrence 3Rectal Neoplasms 3Nasopharyngeal Neoplasms 3Turcot syndrome 2Sarcoma 2Ovarian Neoplasms 2Oropharyngeal Neoplasms 2Neoplasm Metastasis 2Microsatellite Stable Metastatic Colorectal Cancer 2Locally Advanced Rectal Cancer 2Liposarcoma 2Laryngeal Neoplasms 2Gestational Trophoblastic Disease 2Esophageal Neoplasms 2

Interventions

Cisplatin 20Radiotherapy 16Paclitaxel 14Carboplatin 12pembrolizumab 11Drug Therapy 11tislelizumab 10Fluorouracil 8Neoadjuvant Therapy 7130-nm albumin-bound paclitaxel 7sintilimab 5Esophagectomy 5toripalimab 4Tegafur 4TP protocol 4Nivolumab 4Irinotecan 4Immunotherapy 4spartalizumab 3S 1 (combination) 3Oxaliplatin 3Leucovorin 3Itraconazole 3Docetaxel 3Albumin-Bound Paclitaxel 3nimotuzumab 2apatinib 2Taxes 2Radiotherapy, Intensity-Modulated 2Immune Checkpoint Inhibitors 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Esophageal Squamous Cell Carcinoma × toripalimab × Clear all
NCT07177794 2026-04-21

EC-CRT-008

Sun Yat-sen University

Phase 3 Recruiting
242 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT06657144 2026-04-06

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Coherus Oncology, Inc.

Phase 1 Recruiting
154 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT07481058 2026-03-20

KC1036 in Combination With PD-1 Antibody and Platinum-based Chemotherapy for First-line Advanced Esophageal Cancer

Beijing Konruns Pharmaceutical Co., Ltd.

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06187597 2024-03-12

EC-CRT-007

Sun Yat-sen University

Phase 2 Recruiting
140 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡